At Modern Biosciences we seek to in-license the best drug-related intellectual property (IP) from the UK’s premier research institutions and spin-out companies.

In addition to building on the pedigree and established relationships of IP Group plc, a founding investor in Modern Biosciences, we are developing new networks and partnerships to ensure access to the highest quality IP.

Our team combines exceptional expertise in drug development and technology transfer with a proven ability to pick winners and maximise their potential, ensuring that we are able to make the most from the outstanding research base of our partner organisations.